AI-powered precision medicine platform for clinical decision support
Tempus applies machine learning to clinical and molecular data to guide physician decision-making in real time. The stack is heavy on ML infrastructure—PyTorch, TensorFlow, Transformers, Horovod, Ray Data—paired with clinical tools (LIMS, Illumina sequencers) and EHR integration (currently adopting). Active pain points around adoption velocity (online ordering, MRD testing, diagnostic portfolio uptake) and regulatory complexity suggest the company is navigating the friction between AI innovation and clinical workflow embedding, a challenge reflected in their sales-led hiring mix (84 sales roles vs. 22 engineering).
Notable leadership hires: Medical Director, Product Director, Enterprise Solutions Director, Head of Communications, Medical Affairs Director
Tempus AI is a public biotech-tech company applying artificial intelligence to advance precision medicine. The platform ingests clinical and molecular data to generate insights that support real-time, personalized treatment decisions for physicians and patients. Core projects include AI/LLM integration into clinical workflows, real-world evidence studies, liquid biopsy portfolio development, and expansion of laboratory services partnerships. The company operates at scale across the US, Spain, and UK, with balanced investment in sales, research, and data science teams. Regulatory compliance, diagnostic adoption, and clinical workflow integration remain central operational challenges.
Tempus runs PyTorch, TensorFlow, and Transformers as core ML frameworks, supported by Horovod for distributed training, Ray Data for data processing, and Hugging Face Datasets. LangChain and LangGraph indicate recent LLM integration work.
Tempus AI is headquartered in Chicago, IL. The company also hires in Spain and the United Kingdom.
Other companies in the same industry, closest in size